Literature DB >> 21540472

Finding homes for orphan cytochrome P450s: CYP4V2 and CYP4F22 in disease states.

Edward J Kelly1, Mariko Nakano, Priyanka Rohatgi, Vladimir Yarov-Yarovoy, Allan E Rettie.   

Abstract

The cytochrome P450 (CYP) 4 family of enzymes contains several recently identified membersthat are referred to as “orphan P450s” because their endogenous substrates are unknown.Human CYP4V2 and CYP4F22 are two such orphan P450s that are strongly linked to ocular andskin disease, respectively. Genetic analyses have identified a wide spectrum of mutations in the CYP4V2gene from patients suffering from Bietti’s crystalline corneoretinal dystrophy, and mutations in theCYP4F22 gene have been linked to lamellar ichthyosis. The strong gene–disease associations provideunique opportunities for elucidating the substrate specificity of these orphan P450s and unraveling thebiochemical pathways that may be impacted in patients with CYP4V2 and CYP4F22 functional deficits.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21540472      PMCID: PMC3109859          DOI: 10.1124/mi.11.2.10

Source DB:  PubMed          Journal:  Mol Interv        ISSN: 1534-0384


  57 in total

Review 1.  Lipid metabolism in vertebrate retinal rod outer segments.

Authors:  N M Giusto; S J Pasquaré; G A Salvador; P I Castagnet; M E Roque; M G Ilincheta de Boschero
Journal:  Prog Lipid Res       Date:  2000-07       Impact factor: 16.195

2.  Alternative splicing determines the function of CYP4F3 by switching substrate specificity.

Authors:  P Christmas; J P Jones; C J Patten; D A Rock; Y Zheng; S M Cheng; B M Weber; N Carlesso; D T Scadden; A E Rettie; R J Soberman
Journal:  J Biol Chem       Date:  2001-07-18       Impact factor: 5.157

3.  The metabolism of fatty acids in human Bietti crystalline dystrophy.

Authors:  J Lee; X Jiao; J F Hejtmancik; M Kaiser-Kupfer; W A Gahl; T C Markello; J Guo; G J Chader
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-07       Impact factor: 4.799

4.  Expression and characterization of CYP4V2 as a fatty acid omega-hydroxylase.

Authors:  Mariko Nakano; Edward J Kelly; Allan E Rettie
Journal:  Drug Metab Dispos       Date:  2009-08-06       Impact factor: 3.922

5.  Role of peroxisome proliferator-activated receptor alpha in epidermal development in utero.

Authors:  Matthias Schmuth; Kristina Schoonjans; Qian-Chun Yu; Joachim W Fluhr; Debra Crumrine; Jean-Pierre Hachem; Peggy Lau; Johan Auwerx; Peter M Elias; Kenneth R Feingold
Journal:  J Invest Dermatol       Date:  2002-12       Impact factor: 8.551

6.  Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome.

Authors:  C Lefèvre; F Jobard; F Caux; B Bouadjar; A Karaduman; R Heilig; H Lakhdar; A Wollenberg; J L Verret; J Weissenbach; M Ozgüc; M Lathrop; J F Prud'homme; J Fischer
Journal:  Am J Hum Genet       Date:  2001-10-02       Impact factor: 11.025

7.  Genetic linkage of Bietti crystallin corneoretinal dystrophy to chromosome 4q35.

Authors:  X Jiao; F L Munier; F Iwata; M Hayakawa; A Kanai; J Lee; D F Schorderet; M S Chen; M Kaiser-Kupfer; J F Hejtmancik
Journal:  Am J Hum Genet       Date:  2000-09-21       Impact factor: 11.025

8.  Lipoxygenase-3 (ALOXE3) and 12(R)-lipoxygenase (ALOX12B) are mutated in non-bullous congenital ichthyosiform erythroderma (NCIE) linked to chromosome 17p13.1.

Authors:  Florence Jobard; Caroline Lefèvre; Aysen Karaduman; Claudine Blanchet-Bardon; Serap Emre; Jean Weissenbach; Meral Ozgüc; Mark Lathrop; Jean-François Prud'homme; Judith Fischer
Journal:  Hum Mol Genet       Date:  2002-01-01       Impact factor: 6.150

9.  Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation.

Authors:  Song Hong; Karsten Gronert; Pallavi R Devchand; Rose-Laure Moussignac; Charles N Serhan
Journal:  J Biol Chem       Date:  2003-02-17       Impact factor: 5.157

10.  Mutations in the transporter ABCA12 are associated with lamellar ichthyosis type 2.

Authors:  Caroline Lefévre; Stéphanie Audebert; Florence Jobard; Bakar Bouadjar; Hakima Lakhdar; Omar Boughdene-Stambouli; Claudine Blanchet-Bardon; Roland Heilig; Mario Foglio; Jean Weissenbach; Mark Lathrop; Jean-François Prud'homme; Judith Fischer
Journal:  Hum Mol Genet       Date:  2003-07-15       Impact factor: 6.150

View more
  19 in total

1.  CYP4V2 in Bietti's crystalline dystrophy: ocular localization, metabolism of ω-3-polyunsaturated fatty acids, and functional deficit of the p.H331P variant.

Authors:  Mariko Nakano; Edward J Kelly; Constanze Wiek; Helmut Hanenberg; Allan E Rettie
Journal:  Mol Pharmacol       Date:  2012-07-06       Impact factor: 4.436

Review 2.  Ocular cytochrome P450s and transporters: roles in disease and endobiotic and xenobiotic disposition.

Authors:  Mariko Nakano; Catherine M Lockhart; Edward J Kelly; Allan E Rettie
Journal:  Drug Metab Rev       Date:  2014-05-26       Impact factor: 4.518

3.  Longitudinal characterisation of function and structure of Bietti crystalline dystrophy: report on a novel homozygous mutation in CYP4V2.

Authors:  Catherine M Lockhart; Travis B Smith; Paul Yang; Malini Naidu; Allan E Rettie; Abhinav Nath; Richard Weleber; Edward J Kelly
Journal:  Br J Ophthalmol       Date:  2017-07-11       Impact factor: 4.638

4.  Generation and characterization of a murine model of Bietti crystalline dystrophy.

Authors:  Catherine M Lockhart; Mariko Nakano; Allan E Rettie; Edward J Kelly
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-12       Impact factor: 4.799

5.  A novel mutation in the CYP4V2 gene in a Chinese patient with Bietti's crystalline dystrophy.

Authors:  Yanping Song; Guoyan Mo; Guohua Yin
Journal:  Int Ophthalmol       Date:  2012-12-14       Impact factor: 2.031

Review 6.  CYP4 enzymes as potential drug targets: focus on enzyme multiplicity, inducers and inhibitors, and therapeutic modulation of 20-hydroxyeicosatetraenoic acid (20-HETE) synthase and fatty acid ω-hydroxylase activities.

Authors:  Katheryne Z Edson; Allan E Rettie
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

Review 7.  Cytochrome P450 ω-Hydroxylases in Inflammation and Cancer.

Authors:  Amanda L Johnson; Katheryne Z Edson; Rheem A Totah; Allan E Rettie
Journal:  Adv Pharmacol       Date:  2015-06-27

8.  Expression and Functional Characterization of Breast Cancer-Associated Cytochrome P450 4Z1 in Saccharomyces cerevisiae.

Authors:  Matthew G McDonald; Sutapa Ray; Clara J Amorosi; Katherine A Sitko; John P Kowalski; Lorela Paco; Abhinav Nath; Byron Gallis; Rheem A Totah; Maitreya J Dunham; Douglas M Fowler; Allan E Rettie
Journal:  Drug Metab Dispos       Date:  2017-10-10       Impact factor: 3.922

9.  Specific regulation of thermosensitive lipid droplet fusion by a nuclear hormone receptor pathway.

Authors:  Shiwei Li; Qi Li; Yuanyuan Kong; Shuang Wu; Qingpo Cui; Mingming Zhang; Shaobing O Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-31       Impact factor: 11.205

10.  Exome sequencing identifies compound heterozygous mutations in CYP4V2 in a pedigree with retinitis pigmentosa.

Authors:  Yun Wang; Liheng Guo; Su-Ping Cai; Meizhi Dai; Qiaona Yang; Wenhan Yu; Naihong Yan; Xiaomin Zhou; Jin Fu; Xinwu Guo; Pengfei Han; Jun Wang; Xuyang Liu
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.